VOYA Investment Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-13,096
Closed -$37.3K – 2778
2024
Q3
$37.3K Hold
13,096
– – ﹤0.01% 2790
2024
Q2
$30.6K Sell
13,096
-4,921
-27% -$12.8K ﹤0.01% 2819
2024
Q1
$53K Sell
18,017
-3,409
-16% -$9.67K ﹤0.01% 2725
2023
Q4
$64.1K Hold
21,426
– – ﹤0.01% 2825
2023
Q3
$67.7K Hold
21,426
– – ﹤0.01% 2816
2023
Q2
$82.9K Buy
21,426
+672
+3% +$1.94K ﹤0.01% 2835
2023
Q1
$57.5K Hold
20,754
– – ﹤0.01% 2783
2022
Q4
$37.4K Hold
20,754
– – ﹤0.01% 2881
2022
Q3
$44K Hold
20,754
– – ﹤0.01% 2910
2022
Q2
$56K Buy
+20,754
New +$77.2K ﹤0.01% 2725

Other funds holding NAUT

VOYA Investment Management's NAUT Position: Q4 2024 in Review

VOYA Investment Management sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 13,096 shares — an estimated $37.3K sold.

VOYA Investment Management first reported a position in NAUT in Q2 2022 and held it in 10 quarters. The position peaked at $82.9K in Q2 2023. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • VOYA Investment Management reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
  • VOYA Investment Management sold 13,096 Nautilus Biotechnolgy shares in Q4 2024, an estimated $37.3K.
  • VOYA Investment Management first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 10 quarters.
  • VOYA Investment Management's Nautilus Biotechnolgy position peaked at $82.9K in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.